Tus kws kho mob
P30-22 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 02, 2022
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1401 - 1410 ntawm 4303
Tus kws kho mob
P31-22 eviCore Healthcare Specialty Utilization Management (UM) Program - Laboratory Management Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 02, 2022
Tus kws kho mob
P32-22 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans managed by Blue Cross and Blue Shield of Alabama
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 02, 2022
Tus kws kho mob
P33-22 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective July 4, 2022
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 02, 2022
Tus kws kho mob
2022 May Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 02, 2022
Tus kws kho mob
BCBSMN Recredentialing Application for Practitioners
Tus kws kho mob
QP31-22 Medicare Notice of Medicare Non-Coverage (NOMNC) reminder for eviCore
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 27, 2022
Tus kws kho mob
QP32-22 Commercial Pharmacy Benefit Exclusion for EnjaymoTM
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 27, 2022
Tus kws kho mob
QP33-22 MHCP Pharmacy Benefit Exclusion for CarvyktiTM and EnjaymoTM
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 27, 2022